·       Upper-layer NBFCs seek risk-weight rejig amid heightened regulatory scrutiny https://bit.ly/3OVXm0p

·       CPSEs’ capex nears revised annual target with a month to spare https://bit.ly/4bm6GlY

·       Deployment gap widens as companies struggle to operationalise AI https://bit.ly/4ufy1Pa

·       IndiGo resumes Europe flights, Air India adds extra services https://bit.ly/4lkNdqc

·       Exporters withdraw cargo from Customs area amid West Asia security situation https://bit.ly/4aZqCMv

·       India awaits clarity on US maritime reinsurance push for Gulf https://bit.ly/4d5nRuk

·       EU likely to use FTA quotas for premium cars as ‘testbed’ for India manufacturing https://bit.ly/4bcDpK3

·       KIMS enters Karnataka, opens 2 super speciality hospitals in Bengaluru https://bit.ly/4rkHvpI

·       Jaquar Group eyes scaling lighting business revenue to ₹1,700 cr in 3 yrs https://bit.ly/3Nr2clR

·       Swiggy, magicpin, Zomato see food delivery regain growth momentum in Dec qtr https://bit.ly/4rjjBuI

·       Reliance inks deal to bring Finnish chocolate brand Fazer to Indian market https://bit.ly/40g5ziv

·       Alembic enters US branded pharma space; commences sale of antibiotic https://bit.ly/4rYs3R8

·       Novo and Hims end feud, will sell obesity drugs together https://bit.ly/4bm6W4q

·       MRPL denies shutting down refinery units https://bit.ly/4bfoO0w

·       Cipla recalls over 400 cartons of cancer drug in US: USFDA https://bit.ly/3PqP28Y

·       US waiver unlocks Lukoil, Rosneft crude oil for India amid West Asia crisis https://bit.ly/4ufyG36

·       West Asia crisis: Centre working for smooth gas supply to fertiliser plants https://bit.ly/4rZtpuU

·       Awareness of TReDs among MSMEs needs to improve: RXIL's MD & CEO https://bit.ly/4d88elM

·       Delhivery: Why Motilal Oswal sees 35% upside as smart algorithms and hub rerouting drive faster deliveries https://bit.ly/4rmOGhb

·       7 reasons why Indian defence electronics is entering a high-growth super cycle: HDFC Securities https://bit.ly/3OWzNVq

·       Indian Pharma’s Rs 5,000 Cr Risk: Doubling freight cost a key worry as Middle East crisis escalates https://bit.ly/4d8W8c3

·       Tata Consumer Products: Why Nuvama sees 35% upside as the ‘Wellness Pivot’ takes off https://bit.ly/4rl3CfF